-
P210 Efficacy and safety of filgotinib for patients with RA with inadequate response to methotrexate: FINCH1 primary outcome results2020 Lara D. Veeken conference-abstract Medicine Rheumatoid Arthritis Research and Therapies Open access
David Walker, Bernard G Combe, Alan J. Kivitiz, Yoshiya Tanaka, Désirée M F M van der Heijde, Franziska G. Matzkies, +10 more
1citations -
P083 How are beliefs about osteoporosis medicines elicited and addressed in clinical consultations: a video observational study2023 Lara D. Veeken conference-abstract Health Professions Patient-Provider Communication in Healthcare Open access
Ashley Hawarden, Laurna Bullock, Montserrat León‐García, Sandra A. Hartasanchez, Ian G Hargraves, Rob Horne, +4 more
1citations -
P163 Low uveitis rates in patients with axial spondyloarthritis treated with bimekizumab: pooled results from phase 2b/3 trials2024 Lara D. Veeken conference-abstract Medicine Spondyloarthritis Studies and Treatments Open access
Martín Rudwaleit, Matthew Brown, Floris Alexander van Gaalen, Nigil Haroon, Lianne S. Gensler, Carmen Fleurinck, +8 more
1citations -
OA16 Bimekizumab treatment resulted in improvements in MRI inflammatory and structural lesions in the sacroiliac joints of patients with axial spondyloarthritis: 52-week results and post hoc analyses from two Phase 3 studies
Walter P. Maksymowych, Sofía Ramiro, Denis Poddubnyy, Xenofon Baraliakos, Robert George William Lambert, Ute Massow, +4 more
1citations -
P217 Efficacy and safety of filgotinib for patients with RA naïve to MTX therapy: FINCH3 primary outcome results2020 Lara D. Veeken conference-abstract Medicine Rheumatoid Arthritis Research and Therapies Open access
Neil D McKay, Désirée M F M van der Heijde, René Westhovens, William F. C. Rigby, D. W. T. CHING, Beatrix Bartók, +10 more
0citations -
P133 Filgotinib in patients with RA with inadequate response to methotrexate: FINCH 1 52-week efficacy and patient reported outcomes data2021 Lara D. Veeken conference-abstract Medicine Rheumatoid Arthritis Research and Therapies Open access
David Walker, Alan Kivitz, Yoshiya Tanaka, Susan Lee, Lei Ye, Hao Hu, +17 more
0citations -
P187 Safety and efficacy of ixekizumab treatment in patients with axial spondyloarthritis: 3-year results from the COAST programme2023 Lara D. Veeken conference-abstract Medicine Spondyloarthritis Studies and Treatments Open access
Atul A. Deodhar, Denis Poddubnyy, Proton Rahman, Rebecca J. Bolce, Soyi Liu Leage, Andris Kronbergs, +2 more
0citations -
P180 Minimal spinal radiographic progression in patients with radiographic axial spondyloarthritis over 2 years of bimekizumab treatment: results from a phase 3 open-label extension study
Xenofon Baraliakos, Sofía Ramiro, Walter P. Maksymowych, Mikkel Østergaard, Ute Massow, Thomas Vaux, +3 more
0citations -
P115 Long-term efficacy of filgotinib monotherapy and combination therapy: interim results from a post hoc analysis of the FINCH 4 study2025 Rheumatology conference-abstract Medicine Rheumatoid Arthritis Research and Therapies Open access
Maya H Buch, Patrick Verschueren, Roberto Felice Caporali, Tom W. J. Huizinga, Edmund V Ekoka Omoruyi, Dick de Vries, +2 more
0citations -
OA10 Systematic review and independent validation of genetic factors of radiographic outcome in rheumatoid arthritis identifies a genome-wide association with CARD92025 Rheumatology conference-abstract Medicine Rheumatoid Arthritis Research and Therapies Open access
Seema Sharma, Ryan Malcolm Hum, Nisha Nair, Lysette Marshall, John Bowes, Alex J. MacGregor, +6 more
0citations -
OA12 An update on the integrated safety analysis of filgotinib in patients with moderate to severe active rheumatoid arthritis over a median of 4.3 years2025 Rheumatology conference-abstract Medicine Rheumatoid Arthritis Research and Therapies Open access
Kevin L. Winthrop, Daniel Aletaha, Roberto Felice Caporali, Yoshiya Tanaka, Tsutomu Takeuchi, Maya H Buch, +6 more
0citations
14 results